Ongoing Monitoring
Ongoing Monitoring & Clinical Review
Safe prescribing requires regular clinical review and structured follow-up.
How It Works
Scheduled Follow-Up
Follow-up appointments are conducted every 3–4 weeks to assess:
- Weight progress and trends
- Medication tolerability
- Side effects
- Dose suitability
- Changes in medical history
- Ongoing eligibility
Prescribing cannot continue without up-to-date clinical review.
Dose Escalation & Adjustment
Dose increases are introduced gradually and only where clinically appropriate.Escalation depends on:
- Tolerability
- Clinical response
- Absence of significant adverse effects
Dose may be maintained, adjusted, reduced or temporarily paused based on individual response.
Monitoring for Safety
We actively monitor for:
- Gastrointestinal side effects
- Signs of dehydration
- Gallbladder-related symptoms
- Symptoms suggestive of pancreatitis
- Sudden visual changes
- Mood or behavioural changes
If concerns arise, treatment may be paused pending further assessment.
Engagement Requirements
Patients are responsible for:
- Attending scheduled reviews
- Providing accurate and up-to-date information
- Informing us of changes in health status
Failure to maintain engagement may result in treatment being paused or discontinued in order to protect patient safety.